Home LiteratureArticle Details
PMID: 8665471 Published · ppublish English Journal Article Review

Current perspectives on glycopeptide resistance.

Clinical microbiology reviews ·Vol. 8 ·No. 4 ·1995-10-00 ·Pages 585-615

Woodford N, Johnson AP, Morrison D, Speller DC

Abstract

In the last 5 years, clinical isolates of gram-positive bacteria with intrinsic or acquired resistance to glycopeptide antibiotics have been encountered increasingly. In many of these isolates, resistance arises from an alteration of the antibiotic target site, with the terminal D-alanyl-D-alanine moiety of peptidoglycan precursors being replaced by groups that do not bind glycopeptides. Although the criteria for defining resistance have been revised frequently, the reliable detection of low-level glycopeptide resistance remains problematic and is influenced by the method chosen. Glycopeptide-resistant enterococci have emerged as a particular problem in hospitals, where in addition to sporadic cases, clusters of infections with evidence of interpatient spread have occurred. Studies using molecular typing methods have implicated colonization of patients, staff carriage, and environmental contamination in the dissemination of these bacteria. Choice of antimicrobial therapy for infections caused by glycopeptide-resistant bacteria may be complicated by resistance to other antibiotics. Severe therapeutic difficulties are being encountered among patients infected with enterococci, with some infections being untreatable with currently available antibiotics.

MeSH Terms
Anti-Bacterial Agents Cross Infection/drug therapy,epidemiology,microbiology Drug Resistance, Microbial/genetics Drug Therapy, Combination/therapeutic use Glycopeptides Gram-Positive Bacterial Infections/drug therapy,epidemiology,microbiology Gram-Positive Cocci/genetics Microbial Sensitivity Tests
Chemicals
Anti-Bacterial Agents Glycopeptides
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Woodford N
Antibiotic Reference Unit, Central Public Health Laboratory, London, England.
Johnson A P
Morrison D
Speller D C
References (376)
376 references, click to expand
  1. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
    Antimicrob Agents Chemother. 1990 May;34(5):899-900 PMID: 2141780
  2. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients.
    Antimicrob Agents Chemother. 1990 May;34(5):901-3 PMID: 2141781
  3. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.
    Antimicrob Agents Chemother. 1990 May;34(5):924-7 PMID: 2360831
  4. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci.
    J Antimicrob Chemother. 1990 May;25(5):777-85 PMID: 2142683
  5. Clinical and microbiologic characteristics of pediococci.
    J Clin Microbiol. 1990 Jun;28(6):1348-55 PMID: 2380362
  6. Septicemia caused by vancomycin-resistant Pediococcus acidilactici.
    J Clin Microbiol. 1990 Jul;28(7):1678-9 PMID: 2199529
  7. Resistance to vancomycin and teicoplanin: an emerging clinical problem.
    Clin Microbiol Rev. 1990 Jul;3(3):280-91 PMID: 2143434
  8. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):245-52 PMID: 2166634
  9. Infection due to Leuconostoc species: six cases and review.
    Rev Infect Dis. 1990 Jul-Aug;12(4):602-10 PMID: 2201065
  10. Synergism of vancomycin and streptomycin for enterococci.
    Am J Med Sci. 1970 May;259(5):346-9 PMID: 5458569
  11. Erysipelothrix septicaemia without endocarditis.
    Br Med J. 1973 Feb 24;1(5851):464 PMID: 4734731
  12. Lactobacillus casei endocarditis.
    Ann Intern Med. 1975 Apr;82(4):539 PMID: 804288
  13. Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.
    Am J Med. 1978 May;64(5):808-13 PMID: 645745
  14. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    J Infect Dis. 1979 Apr;139(4):452-7 PMID: 438546
  15. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
    Antimicrob Agents Chemother. 1991 Mar;35(3):553-9 PMID: 1903912
  16. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    J Antimicrob Chemother. 1991 Jan;27(1):71-9 PMID: 1828799
  17. Evaluation of the E test, a novel method of quantifying antimicrobial activity.
    J Antimicrob Chemother. 1991 Feb;27(2):185-90 PMID: 2055809
  18. In vitro activity of ramoplanin on staphylococci.
    Drugs Exp Clin Res. 1990;16(9):457-60 PMID: 2100247
  19. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
    Antimicrob Agents Chemother. 1991 May;35(5):955-60 PMID: 1906696
  20. Inducible resistance to vancomycin in Enterococcus faecium D366.
    J Infect Dis. 1989 Jun;159(6):1095-104 PMID: 2723455
  21. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    J Antimicrob Chemother. 1989 Apr;23(4):527-35 PMID: 2745259
  22. Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.
    J Clin Microbiol. 1989 Jun;27(6):1409-10 PMID: 2526821
  23. Cloning of a DNA region of Actinoplanes teichomyceticus conferring teicoplanin resistance.
    FEBS Lett. 1989 Aug 14;253(1-2):108-12 PMID: 2527164
  24. Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.
    BMJ. 1989 Jul 29;299(6694):294-7 PMID: 2504407
  25. High-level vancomycin-resistant enterococci causing hospital infections.
    Epidemiol Infect. 1989 Aug;103(1):173-81 PMID: 2506070
  26. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Antimicrob Agents Chemother. 1989 Jul;33(7):1019-22 PMID: 2506803
  27. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.
    Antimicrob Agents Chemother. 1989 Jul;33(7):1121-4 PMID: 2528940
  28. In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
    Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):279-82 PMID: 2507218
  29. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1989 Aug;33(8):1184-7 PMID: 2802547
  30. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.
    Antimicrob Agents Chemother. 1989 Aug;33(8):1383-4 PMID: 2552910
  31. In vitro activity of vancomycin against enterococci.
    APMIS. 1989 Oct;97(10):897-900 PMID: 2803751
  32. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.
    Lancet. 1989 Nov 4;2(8671):1071-3 PMID: 2572799
  33. Suboptimal effect of daptomycin in the treatment of bacteremias.
    South Med J. 1989 Nov;82(11):1414-5 PMID: 2554510
  34. Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.
    Antimicrob Agents Chemother. 1989 Sep;33(9):1477-81 PMID: 2817848
  35. In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents.
    Antimicrob Agents Chemother. 1992 Apr;36(4):851-3 PMID: 1323955
  36. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods.
    Antimicrob Agents Chemother. 1992 Apr;36(4):854-5 PMID: 1503448
  37. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Apr;36(4):867-9 PMID: 1503450
  38. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic.
    Antimicrob Agents Chemother. 1992 Apr;36(4):873-5 PMID: 1386973
  39. Effects of amino acids on expression of enterococcal vancomycin resistance.
    Antimicrob Agents Chemother. 1992 Apr;36(4):902-5 PMID: 1503457
  40. A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.
    J Infect Dis. 1980 Jan;141(1):81-6 PMID: 6767791
  41. Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli.
    Antimicrob Agents Chemother. 1980 Mar;17(3):359-63 PMID: 6903434
  42. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Antimicrob Agents Chemother. 1982 Sep;22(3):448-52 PMID: 6958215
  43. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
    Ann Intern Med. 1983 Apr;98(4):447-55 PMID: 6838067
  44. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
    Antimicrob Agents Chemother. 1983 Feb;23(2):248-51 PMID: 6340602
  45. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci.
    J Gen Microbiol. 1983 Mar;129(3):813-22 PMID: 6409985
  46. Therapeutic potential of rifampin in enterococcal infections.
    Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S528-32 PMID: 6415781
  47. Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.
    Scand J Infect Dis. 1983;15(4):347-60 PMID: 6361977
  48. Optimal therapy for enterococcal endocarditis.
    Am J Med. 1984 Feb;76(2):186-91 PMID: 6421157
  49. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    J Antimicrob Chemother. 1983 Dec;12 Suppl D:65-78 PMID: 6421794
  50. Susceptibilities of enterococci to twelve antibiotics.
    Antimicrob Agents Chemother. 1984 Apr;25(4):532-3 PMID: 6428309
  51. Vancomycin use--an historical review.
    J Antimicrob Chemother. 1984 Dec;14 Suppl D:1-5 PMID: 6394574
  52. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Antimicrob Agents Chemother. 1985 Jan;27(1):135-6 PMID: 3157344
  53. A prospective study of adverse reactions associated with vancomycin therapy.
    J Antimicrob Chemother. 1985 Aug;16(2):235-41 PMID: 3934126
  54. In vitro activity of ciprofloxacin combined with azlocillin.
    Antimicrob Agents Chemother. 1985 Dec;28(6):849-50 PMID: 2935078
  55. In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.
    J Clin Invest. 1986 Jan;77(1):289-93 PMID: 3080475
  56. Lactobacillus endocarditis.
    J Infect. 1986 Mar;12(2):169-74 PMID: 3084661
  57. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1986 Sep;30(3):382-4 PMID: 3640590
  58. Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature.
    Rev Infect Dis. 1986 Sep-Oct;8(5):771-6 PMID: 3097786
  59. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    J Infect Dis. 1987 Feb;155(2):187-91 PMID: 2949024
  60. Emergence of vancomycin resistance in coagulase-negative staphylococci.
    N Engl J Med. 1987 Apr 9;316(15):927-31 PMID: 3821839
  61. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
    Antimicrob Agents Chemother. 1987 Feb;31(2):139-43 PMID: 3105445
  62. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    J Infect Dis. 1987 Jun;155(6):1226-32 PMID: 3106510
  63. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Antimicrob Agents Chemother. 1987 Mar;31(3):430-3 PMID: 3579260
  64. Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
    Antimicrob Agents Chemother. 1987 Aug;31(8):1199-203 PMID: 2820299
  65. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Diagn Microbiol Infect Dis. 1987 Jun;7(2):127-36 PMID: 3115671
  66. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91 PMID: 2554802
  67. The life and times of the Enterococcus.
    Clin Microbiol Rev. 1990 Jan;3(1):46-65 PMID: 2404568
  68. Two distinct forms of vancomycin resistance amongst enterococci in the UK.
    Lancet. 1990 Jan 27;335(8683):226 PMID: 1967688
  69. Erysipelothrix rhusiopathiae endocarditis.
    Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):50-2 PMID: 2137414
  70. Therapy of enterococcal infections.
    Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):118-26 PMID: 2180707
  71. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
    Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):145-7 PMID: 2138543
  72. Recovery of vancomycin-resistant gram-positive cocci from children.
    J Clin Microbiol. 1990 Mar;28(3):484-8 PMID: 2108993
  73. Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus.
    J Infect Dis. 1990 May;161(5):1036-7 PMID: 2139086
  74. Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia.
    J Infect Dis. 1990 May;161(5):956-60 PMID: 2324545
  75. Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.
    Antimicrob Agents Chemother. 1990 Feb;34(2):252-6 PMID: 2139314
  76. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1990 Feb;34(2):257-60 PMID: 2327773
  77. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 1990 Feb;34(2):273-6 PMID: 2327776
  78. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    J Antimicrob Chemother. 1990 Feb;25(2):217-20 PMID: 2139436
  79. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    J Antimicrob Chemother. 1990 Mar;25(3):491-3 PMID: 2140112
  80. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.
    Antimicrob Agents Chemother. 1990 Apr;34(4):543-9 PMID: 2344161
  81. The potential impact on clinical practice of differences in the in-vitro activity of vancomycin and teicoplanin.
    J Antimicrob Chemother. 1990 Apr;25(4):716-8 PMID: 2141019
  82. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
    J Infect Dis. 1990 Jul;162(1):103-8 PMID: 2141343
  83. Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 1990 Nov;26(5):619-26 PMID: 1964156
  84. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    J Antimicrob Chemother. 1990 Nov;26(5):627-33 PMID: 1688341
  85. Isolation of vancomycin-resistant enterococci in haematologic patients.
    Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):32-4 PMID: 2009875
  86. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin.
    Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):44 PMID: 2009881
  87. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.
    J Infect Dis. 1991 Apr;163(4):780-5 PMID: 1901330
  88. In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.
    Antimicrob Agents Chemother. 1991 Jan;35(1):141-6 PMID: 2014970
  89. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Antimicrob Agents Chemother. 1991 Jan;35(1):195-7 PMID: 1826593
  90. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.
    Antimicrob Agents Chemother. 1991 Jan;35(1):92-8 PMID: 1849711
  91. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):820-2 PMID: 2150815
  92. Infection due to Leuconostoc species.
    Rev Infect Dis. 1991 Jan-Feb;13(1):184-5 PMID: 2017625
  93. Screening and treatment of infections caused by resistant enterococci.
    Antimicrob Agents Chemother. 1991 Feb;35(2):215-9 PMID: 2024952
  94. Vancomycin-resistant Corynebacterium species causing prosthetic valve endocarditis successfully treated with imipenem and ciprofloxacin.
    J Infect. 1991 Mar;22(2):161-9 PMID: 2026890
  95. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient.
    Scand J Infect Dis. 1991;23(1):105-9 PMID: 1902979
  96. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.
    J Clin Microbiol. 1991 Mar;29(3):533-8 PMID: 2037671
  97. Synergistic bactericidal activity of rat serum with vancomycin against enterococci.
    J Infect Dis. 1991 Jun;163(6):1358-61 PMID: 1903800
  98. Increasing prevalence of resistance to ampicillin, penicillin and vancomycin of enterococci isolated from blood cultures during 1990-1991.
    J Antimicrob Chemother. 1993 Feb;31(2):325-6 PMID: 8463178
  99. Aminoglycoside resistant enterococcal endocarditis.
    Infect Dis Clin North Am. 1993 Mar;7(1):117-33 PMID: 8463648
  100. Short-course combination and oral therapies of Staphylococcus aureus endocarditis.
    Infect Dis Clin North Am. 1993 Mar;7(1):69-80 PMID: 8463654
  101. Coagulase-negative staphylococcal bacteraemia treated with teicoplanin.
    J Antimicrob Chemother. 1993 Mar;31(3):438-9 PMID: 8486578
  102. Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates.
    J Antimicrob Chemother. 1993 Mar;31(3):445-7 PMID: 8486582
  103. Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity.
    J Antimicrob Chemother. 1991 Apr;27(4):475-80 PMID: 1830301
  104. Nucleotide sequence to a teicoplanin resistance gene from Actinoplanes teichomyceticus.
    Biochim Biophys Acta. 1991 Jul 23;1089(3):401-3 PMID: 1830492
  105. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.
    Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):141-5 PMID: 1651825
  106. In vitro activity of LY264826 compared to other glycopeptides and daptomycin.
    Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):181-4 PMID: 1651826
  107. Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases.
    Gene. 1991 Jul 15;103(1):133-4 PMID: 1908809
  108. In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
    Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):337-45 PMID: 1889183
  109. Leuconostoc species as a cause of bacteremia: two case reports and a literature review.
    Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):505-9 PMID: 1915386
  110. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae.
    J Hosp Infect. 1991 Jul;18(3):211-8 PMID: 1680903
  111. Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1991 Aug;35(8):1547-50 PMID: 1929325
  112. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Antimicrob Agents Chemother. 1991 Aug;35(8):1570-5 PMID: 1834013
  113. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.
    Biochemistry. 1991 Oct 29;30(43):10408-15 PMID: 1931965
  114. In-vitro activity of trospectomycin against enterococci isolated from blood and other clinical materials.
    J Antimicrob Chemother. 1991 Jun;27(6):873-5 PMID: 1834622
  115. Enterococcus faecium sensitive to teicoplanin but not vancomycin.
    J Hosp Infect. 1991 Aug;18(4):322-4 PMID: 1682372
  116. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.
    Antimicrob Agents Chemother. 1991 Apr;35(4):776-9 PMID: 2069388
  117. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    J Infect Dis. 1991 Nov;164(5):888-93 PMID: 1940467
  118. Vancomycin.
    Mayo Clin Proc. 1991 Nov;66(11):1165-70 PMID: 1943250
  119. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
    Antimicrob Agents Chemother. 1991 Sep;35(9):1919-22 PMID: 1835340
  120. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Antimicrob Agents Chemother. 1990 May;34(5):827-30 PMID: 2141778
  121. Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria.
    J Antimicrob Chemother. 1991 Oct;28(4):483-6 PMID: 1761441
  122. The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.
    J Antimicrob Chemother. 1991 Jul;28(1):1-12 PMID: 1769929
  123. Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin.
    Lancet. 1992 Feb 1;339(8788):312-3 PMID: 1346324
  124. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.
    J Clin Microbiol. 1991 Nov;29(11):2503-6 PMID: 1774255
  125. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    J Clin Microbiol. 1987 Sep;25(9):1812-4 PMID: 2958498
  126. Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
    Antimicrob Agents Chemother. 1987 Jul;31(7):1135-6 PMID: 2821892
  127. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
    J Antimicrob Chemother. 1987 Aug;20(2):191-6 PMID: 2822645
  128. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.
    J Antimicrob Chemother. 1987 Aug;20(2):203-7 PMID: 2822647
  129. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
    J Antimicrob Chemother. 1987 Oct;20(4):609-10 PMID: 2960645
  130. Vancomycin-resistant enterococci.
    Lancet. 1988 Jan 2-9;1(8575-6):57-8 PMID: 2891921
  131. Enterococcal bacteremia in a medical intensive care unit.
    Crit Care Med. 1988 Feb;16(2):126-9 PMID: 3125003
  132. LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
    Antimicrob Agents Chemother. 1988 Jan;32(1):81-3 PMID: 2831816
  133. Clinical laboratory challenges in the recognition of Leuconostoc spp.
    J Clin Microbiol. 1988 Mar;26(3):479-83 PMID: 3128577
  134. Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease.
    Rev Infect Dis. 1988 Mar-Apr;10(2):317-25 PMID: 3287562
  135. Resistance patterns of important gram-positive pathogens.
    J Antimicrob Chemother. 1988 Apr;21 Suppl C:41-7 PMID: 3133348
  136. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
    N Engl J Med. 1988 Jul 21;319(3):157-61 PMID: 2968517
  137. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.
    Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):130-4 PMID: 2968907
  138. The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin.
    J Antimicrob Chemother. 1988 May;21(5):545-54 PMID: 3134318
  139. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.
    Antimicrob Agents Chemother. 1988 Jun;32(6):877-81 PMID: 2843085
  140. Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin.
    J Infect Dis. 1988 Nov;158(5):1144-5 PMID: 3141522
  141. Erysipelothrix rhusiopathiae endocarditis.
    Rev Infect Dis. 1988 Nov-Dec;10(6):1228 PMID: 3206063
  142. Enterococcal bacteremia: analysis of 75 episodes.
    Rev Infect Dis. 1989 Jan-Feb;11(1):74-85 PMID: 2916096
  143. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.
    JAMA. 1989 Mar 10;261(10):1471-7 PMID: 2645447
  144. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.
    Antimicrob Agents Chemother. 1989 Jan;33(1):10-5 PMID: 2523687
  145. In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.
    Antimicrob Agents Chemother. 1989 Jan;33(1):71-7 PMID: 2496659
  146. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.
    Antimicrob Agents Chemother. 1989 Feb;33(2):198-203 PMID: 2497704
  147. Enterococcal superinfection in paediatric oncology patients treated with imipenem.
    Lancet. 1992 Jun 13;339(8807):1487-8 PMID: 1351170
  148. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers.
    Ann Intern Med. 1992 Jul 15;117(2):112-6 PMID: 1605425
  149. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Antimicrob Agents Chemother. 1992 Feb;36(2):331-8 PMID: 1534977
  150. Antibiotic-resistant enterococci.
    J Hosp Infect. 1992 May;21(1):1-14 PMID: 1351492
  151. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    APMIS. 1992 Jun;100(6):543-52 PMID: 1535201
  152. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis.
    Clin Infect Dis. 1992 Jul;15(1):49-57 PMID: 1617073
  153. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Clin Infect Dis. 1992 Jul;15(1):58-62 PMID: 1319757
  154. Enterococcal endocarditis.
    Clin Infect Dis. 1992 Jul;15(1):63-71 PMID: 1617074
  155. Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100.
    FEMS Microbiol Lett. 1992 Apr 1;71(1):11-4 PMID: 1320585
  156. Detection of vancomycin resistance in Enterococcus species.
    J Clin Microbiol. 1992 Jul;30(7):1621-4 PMID: 1629315
  157. [Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].
    Enferm Infecc Microbiol Clin. 1991 Nov;9(9):547-50 PMID: 1668361
  158. The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases.
    Diagn Microbiol Infect Dis. 1992 Jul;15(5):459-63 PMID: 1643825
  159. [Endocarditis caused by Lactobacillus].
    Enferm Infecc Microbiol Clin. 1992 Jan;10(1):32-3 PMID: 1498171
  160. Evaluation of the E test by using selected gram-positive bacteria.
    J Clin Microbiol. 1992 Aug;30(8):2150-2 PMID: 1500524
  161. Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium.
    Antimicrob Agents Chemother. 1992 Apr;36(4):783-7 PMID: 1503440
  162. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth.
    Ann Intern Med. 1994 Jul 1;121(1):22-6 PMID: 8198343
  163. Alterations in peptidoglycan precursors and vancomycin susceptibility in Tn917 insertion mutants of Enterococcus faecalis 221.
    Antimicrob Agents Chemother. 1994 Mar;38(3):473-5 PMID: 8203839
  164. In vitro activities of two glycylcyclines against gram-positive bacteria.
    Antimicrob Agents Chemother. 1994 Mar;38(3):534-41 PMID: 8203851
  165. Rare diseases and orphan drugs.
    Lancet. 1994 Jun 18;343(8912):1560-1 PMID: 7911879
  166. Heat resistance of nosocomial enterococci.
    Lancet. 1994 Jul 2;344(8914):64-5 PMID: 7912336
  167. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.
    FEMS Microbiol Lett. 1992 Jun 1;72(2):195-8 PMID: 1505742
  168. Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.
    J Antimicrob Chemother. 1992 Jun;29(6):725-7 PMID: 1387134
  169. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.
    Antimicrob Agents Chemother. 1992 May;36(5):1109-14 PMID: 1324637
  170. Vancomycin resistance in Enterococcus gallinarum.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1392-9 PMID: 1510433
  171. Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1487-90 PMID: 1510445
  172. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1491-8 PMID: 1324647
  173. Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1514-8 PMID: 1510448
  174. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1563-6 PMID: 1510455
  175. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Antimicrob Agents Chemother. 1992 Jul;36(7):1570-2 PMID: 1324649
  176. Two cases of endocarditis due to Lactobacillus species: antimicrobial susceptibility, review, and discussion of therapy.
    Clin Infect Dis. 1992 Aug;15(2):250-5 PMID: 1520759
  177. Bactericidal activity of antibiotics alone and in combination against Enterococcus faecalis in a pharmacodynamic model.
    Clin Infect Dis. 1992 Sep;15(3):481-5 PMID: 1520797
  178. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.
    FEMS Microbiol Lett. 1992 Jul 1;73(1-2):195-200 PMID: 1521770
  179. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
    J Bacteriol. 1992 Sep;174(18):5982-4 PMID: 1522072
  180. Characterization and antibiotic susceptibility of Pediococcus acidilactici strains isolated from neutropenic patients.
    Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):383-5 PMID: 1396762
  181. Septicemia and hepatic abscess caused by Pediococcus acidilactici.
    Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):623-5 PMID: 1396771
  182. Sequence of the vanY gene required for production of a vancomycin-inducible D,D-carboxypeptidase in Enterococcus faecium BM4147.
    Gene. 1992 Oct 12;120(1):111-4 PMID: 1398115
  183. A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500.
    J Antimicrob Chemother. 1992 Jul;30 Suppl A:123-31 PMID: 1399944
  184. Enterococci and antifolate antibiotics.
    Eur J Clin Microbiol. 1986 Aug;5(4):391-4 PMID: 3093220
  185. Comparative in-vitro activity of RP 59500.
    J Antimicrob Chemother. 1992 Jul;30 Suppl A:39-44 PMID: 1399949
  186. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
    J Antimicrob Chemother. 1992 Jul;30 Suppl A:59-65 PMID: 1399952
  187. New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.
    J Clin Microbiol. 1992 Oct;30(10):2525-8 PMID: 1400949
  188. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.
    J Clin Microbiol. 1992 Sep;30(9):2373-8 PMID: 1401001
  189. Different modes of vancomycin and D-alanyl-D-alanine peptidase binding to cell wall peptide and a possible role for the vancomycin resistance protein.
    Antimicrob Agents Chemother. 1990 Jul;34(7):1342-7 PMID: 2386365
  190. WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.
    Antimicrob Agents Chemother. 1990 Jul;34(7):1376-80 PMID: 2117417
  191. Characterization of Leuconostoc lactis strains from human sources.
    J Clin Microbiol. 1990 Aug;28(8):1728-33 PMID: 2394800
  192. Comparison of vancomycin-inducible proteins from four strains of Enterococci.
    FEMS Microbiol Lett. 1990 Jun 15;58(1):101-5 PMID: 2118867
  193. Induction of vancomycin resistance in Enterococcus faecium by inhibition of transglycosylation.
    FEMS Microbiol Lett. 1990 Jul;58(2):167-70 PMID: 2227352
  194. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection.
    J Clin Microbiol. 1990 Sep;28(9):2064-8 PMID: 2229388
  195. Meningitis in a neonate caused by Leuconostoc sp.
    J Clin Microbiol. 1990 Sep;28(9):2125-6 PMID: 2229396
  196. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward.
    N Engl J Med. 1990 Dec 27;323(26):1814-8 PMID: 2123301
  197. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.
    J Infect Dis. 1991 Jan;163(1):204-5 PMID: 1984473
  198. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis.
    Lancet. 1991 Jan 5;337(8732):54 PMID: 1670676
  199. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.
    Mol Gen Genet. 1990 Dec;224(3):364-72 PMID: 2266943
  200. Lactobacillus jensenii prosthetic valve endocarditis.
    J Infect. 1990 Nov;21(3):322-4 PMID: 2273281
  201. Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1769-72 PMID: 2285289
  202. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1792-4 PMID: 2126691
  203. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1800-2 PMID: 2126692
  204. In vitro detection of enterococcal vancomycin resistance.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1846-8 PMID: 2126696
  205. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.
    Antimicrob Agents Chemother. 1990 Oct;34(10):1875-9 PMID: 2291654
  206. Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model.
    Antimicrob Agents Chemother. 1990 Oct;34(10):1925-31 PMID: 1963288
  207. Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae.
    Antimicrob Agents Chemother. 1990 Oct;34(10):2038-40 PMID: 2291674
  208. Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity.
    Biochemistry. 1991 Feb 26;30(8):2017-21 PMID: 1998664
  209. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.
    J Antimicrob Chemother. 1990 Dec;26 Suppl F:165-79 PMID: 2127272
  210. Tricuspid valve infective endocarditis and pulmonary sepsis due to Erysipelothrix rhusiopathiae successfully treated with high doses of ciprofloxacin but complicated by gynaecomastia.
    J Infect. 1991 Jan;22(1):100-1 PMID: 2002222
  211. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
    Antimicrob Agents Chemother. 1992 Dec;36(12):2611-6 PMID: 1336339
  212. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.
    Antimicrob Agents Chemother. 1992 Dec;36(12):2709-14 PMID: 1336344
  213. Increasing resistance of enterococci to ciprofloxacin.
    Antimicrob Agents Chemother. 1992 Nov;36(11):2533-5 PMID: 1489199
  214. Comparison of Streptex versus PathoDx for group D typing of vancomycin-resistant Enterococcus.
    Diagn Microbiol Infect Dis. 1993 Jan;16(1):89-91 PMID: 8425383
  215. CAPD peritonitis caused by Lactobacillus rhamnosus.
    J Hosp Infect. 1992 Dec;22(4):325-7 PMID: 1363113
  216. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.
    J Antimicrob Chemother. 1992 Dec;30(6):753-68 PMID: 1289350
  217. Vancomycin-resistant Enterococcus faecium in hospitalized children.
    Infect Control Hosp Epidemiol. 1992 Dec;13(12):700-5 PMID: 1289397
  218. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides.
    FEMS Microbiol Lett. 1993 Jan 1;106(1):23-9 PMID: 8440464
  219. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.
    Gene. 1993 Feb 14;124(1):143-4 PMID: 8440477
  220. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
    J Antimicrob Chemother. 1993 Jan;31(1):182-5 PMID: 8444668
  221. Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.
    J Antimicrob Chemother. 1993 Jan;31(1):188-91 PMID: 8444670
  222. In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
    Antimicrob Agents Chemother. 1993 Feb;37(2):366-70 PMID: 8452372
  223. In vitro activity of cefdinir (FK 482, PD 134393, CI-983): a new orally active cephalosporin.
    Chemotherapy. 1993 Mar-Apr;39(2):112-9 PMID: 8458243
  224. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci.
    J Clin Microbiol. 1993 Mar;31(3):653-8 PMID: 8096216
  225. In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
    Antimicrob Agents Chemother. 1993 Mar;37(3):598-601 PMID: 8460927
  226. Rapid detection of vancomycin-resistant enterococci.
    J Clin Microbiol. 1994 Sep;32(9):2182-4 PMID: 7814543
  227. Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp.
    Gene. 1995 Jan 11;152(1):79-83 PMID: 7828933
  228. Antimicrobial susceptibility of coagulase-negative staphylococci.
    Antimicrob Agents Chemother. 1994 Oct;38(10):2231-7 PMID: 7840550
  229. Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum".
    J Clin Microbiol. 1994 Nov;32(11):2686-91 PMID: 7852557
  230. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.
    J Clin Microbiol. 1994 Nov;32(11):2840-2 PMID: 7852582
  231. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci.
    J Infect Dis. 1993 May;167(5):1220-3 PMID: 8486958
  232. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.
    J Infect Dis. 1993 May;167(5):1224-7 PMID: 8486959
  233. Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020.
    Antimicrob Agents Chemother. 1993 Apr;37(4):789-92 PMID: 8494376
  234. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Antimicrob Agents Chemother. 1993 Apr;37(4):896-900 PMID: 8494388
  235. Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147.
    Biochemistry. 1993 May 18;32(19):5057-63 PMID: 8494882
  236. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.
    J Clin Microbiol. 1993 May;31(5):1280-5 PMID: 8501230
  237. Comparative antibacterial activity of the aminothiazolyl cephalosporin RU 29,246.
    Chemotherapy. 1993 May-Jun;39(3):175-81 PMID: 8508687
  238. Comparison of ribotyping and pulsed-field gel electrophoresis for subspecies differentiation of strains of Enterococcus faecalis.
    J Clin Microbiol. 1993 Jun;31(6):1570-4 PMID: 8314998
  239. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.
    J Clin Microbiol. 1993 Jun;31(6):1609-11 PMID: 8315004
  240. Enterococcus faecium: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains.
    Chemotherapy. 1993 Jul-Aug;39(4):254-64 PMID: 8325127
  241. Emergence of vancomycin-resistant enterococci in New York City.
    Lancet. 1993 Jul 10;342(8863):76-9 PMID: 8100912
  242. Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.
    Antimicrob Agents Chemother. 1993 Jun;37(6):1238-42 PMID: 8328775
  243. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Antimicrob Agents Chemother. 1993 Jun;37(6):1364-6 PMID: 8328787
  244. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
    Clin Infect Dis. 1993 Jun;16(6):750-5 PMID: 8329505
  245. In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.
    J Antimicrob Chemother. 1993 May;31(5):711-23 PMID: 8335499
  246. The Enterococcus endocarditis model in experimental animals and its relevance to human infection.
    J Antimicrob Chemother. 1993 May;31 Suppl D:87-95 PMID: 8335527
  247. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci.
    J Clin Microbiol. 1993 Jul;31(7):1695-9 PMID: 8349745
  248. Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.
    J Infect. 1991 Sep;23(2):179-82 PMID: 1753117
  249. Vancomycin-resistant enterococci.
    Lancet. 1993 Sep 4;342(8871):616-7 PMID: 8102743
  250. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51 PMID: 8363374
  251. An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis.
    J Med Microbiol. 1993 Sep;39(3):204-10 PMID: 8366519
  252. The emergence of vancomycin resistance in renal dialysis.
    J Hosp Infect. 1993 Jul;24(3):167-73 PMID: 8104207
  253. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.
    J Clin Microbiol. 1991 Sep;29(9):1888-92 PMID: 1685496
  254. Abscess caused by vancomycin-resistant Lactobacillus confusus.
    J Clin Microbiol. 1991 Sep;29(9):2063-4 PMID: 1774335
  255. In vitro activity of flomoxef and cefazolin in combination with vancomycin.
    Infection. 1991;19 Suppl 5:S276-8 PMID: 1783443
  256. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Chemotherapy. 1991;37(4):275-82 PMID: 1665123
  257. Occurrence of Leuconostoc mesenteroides and leuconostoc-like organisms in Lagos, Nigeria.
    East Afr Med J. 1991 Dec;68(12):969-74 PMID: 1800096
  258. Vancomycin resistance in south London.
    Lancet. 1992 Mar 28;339(8796):818-9 PMID: 1347850
  259. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis.
    Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1007-12 PMID: 1802693
  260. Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.
    Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1062-5 PMID: 1666362
  261. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance.
    Gene. 1992 Mar 1;112(1):53-8 PMID: 1551598
  262. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
    J Bacteriol. 1992 Apr;174(8):2582-91 PMID: 1556077
  263. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci.
    Clin Infect Dis. 1992 Mar;14(3):655-61 PMID: 1562656
  264. Clustered bacteremias in a hemodialysis unit: cross-contamination of blood tubing from ultrafiltrate waste.
    Infect Control Hosp Epidemiol. 1992 Mar;13(3):160-4 PMID: 1564314
  265. Chlorhexidine sensitivity of Enterococcus faecium resistant to vancomycin, high levels of gentamicin, or both.
    J Hosp Infect. 1992 Feb;20(2):127-8 PMID: 1348760
  266. Effect of protein binding of daptomycin on MIC and antibacterial activity.
    Antimicrob Agents Chemother. 1991 Dec;35(12):2505-8 PMID: 1667253
  267. In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model.
    Diagn Microbiol Infect Dis. 1992 Feb;15(2):173-6 PMID: 1315234
  268. Comparative in vitro activity of the new glycopeptide SK&F 104662 against problematic gram-positive bacteria.
    Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):782-4 PMID: 1810738
  269. Typing of Enterococcus species by DNA restriction fragment analysis.
    J Clin Microbiol. 1992 Apr;30(4):915-9 PMID: 1315338
  270. Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-beta-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366.
    FEMS Microbiol Lett. 1992 Feb 1;70(1):79-84 PMID: 1577257
  271. Diffusion of teicoplanin and vancomycin in agar.
    Diagn Microbiol Infect Dis. 1992 Mar-Apr;15(3):253-8 PMID: 1533826
  272. Inducible carboxypeptidase activity in vancomycin-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Jan;36(1):77-80 PMID: 1534213
  273. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.
    Infect Control Hosp Epidemiol. 1992 Apr;13(4):195-200 PMID: 1593099
  274. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    J Antimicrob Chemother. 1992 Apr;29 Suppl A:25-30 PMID: 1601753
  275. Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2311-7 PMID: 8285611
  276. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2427-31 PMID: 8285628
  277. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2432-7 PMID: 8285629
  278. Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 1993 Nov;37(11):2470-3 PMID: 8285636
  279. Vancomycin binding to cell walls of non-streptococcal vancomycin-resistant bacteria.
    J Antimicrob Chemother. 1993 Oct;32(4):551-8 PMID: 8288496
  280. Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups.
    J Appl Bacteriol. 1993 Nov;75(5):399-408 PMID: 8300442
  281. Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.
    J Clin Microbiol. 1993 Dec;31(12):3336-9 PMID: 8308134
  282. Glycopeptide sensitivity of staphylococci.
    J Infect. 1993 Nov;27(3):335-8 PMID: 8308329
  283. In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
    Antimicrob Agents Chemother. 1993 Dec;37(12):2563-70 PMID: 8109918
  284. In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.
    Antimicrob Agents Chemother. 1993 Dec;37(12):2736-9 PMID: 8109945
  285. Sequence of the vanB and ddl genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583.
    Gene. 1994 Mar 11;140(1):97-102 PMID: 8125347
  286. Towards the ideal glycopeptide.
    J Antimicrob Chemother. 1993 Nov;32(5):663-6 PMID: 8125830
  287. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    J Antimicrob Chemother. 1993 Nov;32(5):715-21 PMID: 8125836
  288. Dosage recommendations for teicoplanin.
    J Antimicrob Chemother. 1993 Dec;32(6):792-6 PMID: 8144419
  289. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum.
    J Bacteriol. 1994 Apr;176(8):2398-405 PMID: 8157610
  290. Impact of the agar medium and disc type on disc diffusion susceptibility testing against teicoplanin and vancomycin.
    APMIS. 1994 Feb;102(2):94-102 PMID: 8167013
  291. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium.
    J Antimicrob Chemother. 1994 Feb;33(2):319-21 PMID: 8182013
  292. An in-vitro investigation of the susceptibility of Enterococcus faecalis to clofazimine and B669.
    J Antimicrob Chemother. 1994 Feb;33(2):356-8 PMID: 8182023
  293. New quinolones and gram-positive bacteria.
    Antimicrob Agents Chemother. 1994 Feb;38(2):163-9 PMID: 8192436
  294. Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 1994 Feb;38(2):385-7 PMID: 8192473
  295. Therapeutic beds: the Trojan horses of the 1990s?
    Lancet. 1994 Jul 2;344(8914):65-6 PMID: 7912337
  296. Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.
    Antimicrob Agents Chemother. 1994 Apr;38(4):824-9 PMID: 8031053
  297. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174.
    Biochem J. 1994 Jul 1;301 ( Pt 1):5-8 PMID: 8037690
  298. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage.
    J Antimicrob Chemother. 1994 Mar;33(3):553-61 PMID: 8040119
  299. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.
    Eur J Clin Microbiol Infect Dis. 1994 Mar;13(3):238-46 PMID: 8050437
  300. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome.
    FEMS Microbiol Lett. 1994 Jun 15;119(3):359-63 PMID: 8050717
  301. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.
    J Clin Microbiol. 1994 May;32(5):1148-53 PMID: 8051238
  302. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin.
    Diagn Microbiol Infect Dis. 1994 Feb;18(2):105-9 PMID: 8062527
  303. Vancomycin-resistant enterococci and bedpan washer machines.
    Lancet. 1994 Sep 3;344(8923):685 PMID: 7915371
  304. Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents.
    J Antimicrob Chemother. 1994 May;33(5):1060-4 PMID: 8089056
  305. Vancomycin-dependent enterococci in the United Kingdom.
    J Antimicrob Chemother. 1994 May;33(5):1066 PMID: 8089058
  306. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Antimicrob Agents Chemother. 1994 Jun;38(6):1225-9 PMID: 8092818
  307. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.
    Antimicrob Agents Chemother. 1994 Jun;38(6):1363-7 PMID: 8092838
  308. Development of a standardized screening method for detection of vancomycin-resistant enterococci.
    J Clin Microbiol. 1994 Jul;32(7):1700-4 PMID: 7929760
  309. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.
    Lancet. 1994 Oct 8;344(8928):1025-6 PMID: 7934410
  310. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents.
    Clin Infect Dis. 1994 Jul;19(1):163-5 PMID: 7948523
  311. Do nonclinical uses of antibiotics make a difference?
    Infect Control Hosp Epidemiol. 1994 Jul;15(7):484-7 PMID: 7963441
  312. The in-vitro activity of RP 59500 against gram-positive cocci.
    J Antimicrob Chemother. 1992 Jul;30 Suppl A:25-8 PMID: 1399947
  313. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Antimicrob Agents Chemother. 1995 Feb;39(2):400-5 PMID: 7726505
  314. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome.
    Clin Infect Dis. 1995 Feb;20(2):296-301 PMID: 7742433
  315. Bacteremia due to vancomycin-dependent Enterococcus faecium.
    Clin Infect Dis. 1995 Mar;20(3):712-4 PMID: 7756503
  316. Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis.
    J Antimicrob Chemother. 1995 Jan;35(1):179-84 PMID: 7768767
  317. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.
    J Infect Dis. 1995 Jun;171(6):1646-50 PMID: 7769310
  318. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.
    Antimicrob Agents Chemother. 1995 Apr;39(4):830-3 PMID: 7785979
  319. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
    J Clin Microbiol. 1995 May;33(5):1434 PMID: 7615777
  320. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum.
    Antimicrob Agents Chemother. 1995 Jul;39(7):1480-4 PMID: 7492089
  321. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure.
    Microb Drug Resist. 1995 Spring;1(1):95-6 PMID: 9156389
  322. Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases.
    Circulation. 1954 Aug;10(2):173-94 PMID: 13182750
  323. Identification of vancomycin-resistant lactic bacteria isolated from humans.
    J Clin Microbiol. 1993 Sep;31(9):2499-501 PMID: 8408575
  324. Glycopeptide-resistant Gemella haemolysans from blood.
    Lancet. 1993 Oct 9;342(8876):927-8 PMID: 8105186
  325. Genetics and mechanisms of glycopeptide resistance in enterococci.
    Antimicrob Agents Chemother. 1993 Aug;37(8):1563-71 PMID: 8215264
  326. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.
    Antimicrob Agents Chemother. 1993 Aug;37(8):1604-9 PMID: 8215270
  327. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart.
    Clin Infect Dis. 1993 Sep;17(3):524-5 PMID: 8218712
  328. Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia.
    Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):649-50 PMID: 8223672
  329. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    J Antimicrob Chemother. 1993 Aug;32(2):267-78 PMID: 8226428
  330. Antimicrobial resistance amongst enterococci isolated in the United Kingdom: a reference laboratory perspective.
    J Antimicrob Chemother. 1993 Aug;32(2):344-6 PMID: 8226440
  331. Erysipelothrix endocarditis affecting a porcine xenograft heart valve.
    J Infect. 1993 Sep;27(2):203-4 PMID: 8228304
  332. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Antimicrob Agents Chemother. 1993 Sep;37(9):1904-8 PMID: 8239604
  333. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.
    Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):151-5 PMID: 8243036
  334. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Pathol Biol (Paris). 1993 Jun;41(6):531-6 PMID: 8247632
  335. Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1.
    J Clin Microbiol. 1993 Oct;31(10):2777-9 PMID: 8253981
  336. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 1993 Oct;37(10):2069-73 PMID: 8257125
  337. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology.
    J Antimicrob Chemother. 1993 Sep;32(3):401-11 PMID: 8262862
  338. Persistent bacteremia with Erysipelothrix rhusiopathiae in a hospitalized patient.
    Clin Infect Dis. 1993 Oct;17(4):783-4 PMID: 8268364
  339. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate.
    J Bacteriol. 1994 Jan;176(1):260-4 PMID: 8282706
  340. Enterococcal bacteraemia: a prospective study of 125 episodes.
    J Hosp Infect. 1994 Jul;27(3):179-86 PMID: 7963458
  341. Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 1994 Jul;38(7):1668-70 PMID: 7979306
  342. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.
    Antimicrob Agents Chemother. 1994 Jul;38(7):1675-7 PMID: 7979308
  343. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.
    Antimicrob Agents Chemother. 1994 Aug;38(8):1788-93 PMID: 7986009
  344. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.
    Antimicrob Agents Chemother. 1994 Sep;38(9):1899-903 PMID: 7810996
  345. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility.
    J Infect Dis. 1992 Nov;166(5):1066-72 PMID: 1402017
  346. Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s.
    JAMA. 1992 Nov 11;268(18):2563-4 PMID: 1308665
  347. Vancomycin-resistant Enterococcus durans.
    Lancet. 1992 Oct 31;340(8827):1105 PMID: 1357503
  348. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
    Antimicrob Agents Chemother. 1992 Jun;36(6):1192-7 PMID: 1329613
  349. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
    Antimicrob Agents Chemother. 1992 Jun;36(6):1256-62 PMID: 1416824
  350. Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci.
    Antimicrob Agents Chemother. 1992 Jun;36(6):1325-8 PMID: 1329621
  351. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Sep;36(9):1864-9 PMID: 1329632
  352. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.
    Antimicrob Agents Chemother. 1992 Sep;36(9):2005-8 PMID: 1416893
  353. Life-threatening Pseudomonas aeruginosa infections in patients with infection due to human immunodeficiency virus.
    Clin Infect Dis. 1992 Oct;15(4):751-2 PMID: 1420706
  354. Bacteremia due to vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin.
    Clin Infect Dis. 1992 Oct;15(4):752-3 PMID: 1420707
  355. Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria.
    Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):609-12 PMID: 1424518
  356. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates.
    Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):641-4 PMID: 1424522
  357. In vitro activity of the new glycopeptide decaplanin.
    Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62 PMID: 1330562
  358. Review of nocardial infections in France 1987 to 1990.
    Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):709-14 PMID: 1425729
  359. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
    Antimicrob Agents Chemother. 1992 Oct;36(10):2185-91 PMID: 1332589
  360. Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Oct;36(10):2201-3 PMID: 1444300
  361. Bactericidal activity of ramoplanin against antibiotic-resistant enterococci.
    Antimicrob Agents Chemother. 1992 Oct;36(10):2342-5 PMID: 1444316
  362. Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.
    J Clin Microbiol. 1992 Nov;30(11):2757-61 PMID: 1333477
  363. Vancomycin-resistant enterococci in a district general hospital.
    Lancet. 1992 Dec 12;340(8833):1471-2 PMID: 1360587
  364. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
    Microbios. 1992;71(287):95-103 PMID: 1453987
  365. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium.
    FEMS Microbiol Lett. 1992 Nov 1;77(1-3):109-15 PMID: 1459398
  366. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
    J Bacteriol. 1993 Jan;175(1):117-27 PMID: 8380148
  367. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.
    Mol Microbiol. 1994 Sep;13(6):1065-70 PMID: 7854121
  368. Bacterial sensor kinase/response regulator systems: an introduction.
    Res Microbiol. 1994 Jun-Aug;145(5-6):349-55 PMID: 7855419
  369. Detection of vancomycin resistance in enterococci by the Vitek AMS system.
    Diagn Microbiol Infect Dis. 1994 Oct;20(2):113-6 PMID: 7867304
  370. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin.
    Gene. 1995 Feb 27;154(1):87-92 PMID: 7867956
  371. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.
    J Antimicrob Chemother. 1994 Oct;34(4):507-14 PMID: 7868403
  372. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 1994 Oct;34(4):515-28 PMID: 7868404
  373. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry.
    FEMS Microbiol Lett. 1995 Jan 15;125(2-3):165-71 PMID: 7875564
  374. Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
    J Antimicrob Chemother. 1994 Nov;34(5):797-802 PMID: 7706176
  375. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States.
    Antimicrob Agents Chemother. 1995 Feb;39(2):362-8 PMID: 7726499
  376. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
    J Infect Dis. 1993 Sep;168(3):681-6 PMID: 8354909
Article Info
Journal
Clinical microbiology reviews
Abbr.
Clin Microbiol Rev
ISSN
0893-8512
DOI
10.1128/CMR.8.4.585
Published
1995-10-00
Pages
585-615
Language
English
Region
United States
NLM ID
8807282
PMCID
PMC172877
Subset
IM
External Links
PubMed source DOI: 10.1128/CMR.8.4.585 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2